TL;DR: The Centers for Medicare & Medicaid Services modified NCD 380, the Medicare coverage policy governing home use of Noninvasive Positive Pressure Ventilation (NIPPV) for Chronic Respiratory Failure (CRF) consequent to COPD, with an effective date of January 31, 2026. Here's what changes for billing teams.

This update affects durable medical equipment (DME) suppliers and pulmonary billing teams who submit claims for Respiratory Assist Devices (RADs) and Home Mechanical Ventilators (HMVs) under the Medicare DME benefit. The policy does not list specific HCPCS codes in its current published form — but the clinical criteria are detailed and the documentation requirements are strict. Miss one, and you're looking at a claim denial.


Quick-Reference Table

Field Detail
Payer CMS (Centers for Medicare & Medicaid Services)
Policy Noninvasive Positive Pressure Ventilation (NIPPV) in the Home for the Treatment of Chronic Respiratory Failure Consequent to COPD
Policy Code NCD 380 Medicare
Change Type Modified
Effective Date January 31, 2026
Impact Level High
Specialties Affected Pulmonology, Sleep Medicine, DME Suppliers, Home Health, Respiratory Therapy
Key Action Audit all active RAD and HMV cases for compliance with updated initial coverage, continuing usage, and non-coverage criteria before January 31, 2026

CMS NIPPV Coverage Criteria and Medical Necessity Requirements 2026

The CMS NIPPV coverage policy under NCD 380 splits into two main device categories: Respiratory Assist Devices (RADs) and Home Mechanical Ventilators (HMVs). These are not interchangeable for billing purposes. HMVs have more ventilatory modes, monitoring, and safety features — including backup power — than RADs. Which device a patient receives determines which medical necessity criteria apply.

RAD with Backup Rate Feature

To cover a RAD with backup rate feature for high intensity noninvasive ventilation (NIV), CMS requires all of the following for the initial six-month coverage period:

#Covered Indication
1PaCO2 ≥ 52 mmHg by arterial blood gas (ABG) during awake hours while breathing the patient's prescribed FiO2
2Sleep apnea is not the predominant cause of the hypercapnia (formal sleep testing is not required if the treating clinician determines this clinically)
3The patient meets one of these stability conditions:
    Stable COPD, defined as no increase in or new onset of more than one respiratory symptom (cough, sputum production, sputum purulence, wheezing, or dyspnea) for two or more days, and no pharmacological treatment change in the two weeks before NIV initiation
+ 1 more indications

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

By the end of the initial six-month period, the device must be used as high intensity therapy. That means a minimum IPAP of 15 cm H2O and a backup respiratory rate of at least 14 breaths per minute. This is a hard threshold — document it.

RAD without Backup Rate Feature

CMS will cover a RAD without backup rate feature when a patient with CRF consequent to COPD cannot tolerate high intensity NIV, or when the backup rate feature is otherwise medically inappropriate. The threshold is the same: PaCO2 ≥ 52 mmHg by ABG during awake hours on prescribed FiO2, and sleep apnea must not be the predominant cause of hypercapnia.

This is the fallback device option. If you're billing for a RAD without backup rate, your documentation needs to show why high intensity NIV wasn't appropriate. "Patient preference" alone won't hold up.

RAD Upon Hospital Discharge

CMS added specific language for patients discharged with acute on chronic respiratory failure due to COPD. A RAD with or without backup rate feature is covered immediately upon discharge for an initial six-month period if:

#Covered Indication
1The patient required a RAD or ventilator within 24 hours before hospital discharge
2The treating clinician determined the patient is at risk of rapid symptom exacerbation or PaCO2 rise after discharge

This pathway is practical — it closes the gap for patients who can't meet the stable outpatient criteria. But the 24-hour window before discharge and the clinician's risk determination both need to be in the medical record. Get that documentation before the patient leaves the building.

Continuing Usage Criteria

Initial six-month coverage is just the start. To continue coverage beyond that period, patients must be evaluated at least twice in the first year after initially receiving a RAD. These evaluations must occur. Missing them creates a coverage gap and a reimbursement risk that's entirely avoidable.

The policy requires ongoing clinical re-evaluation. If your billing team is managing long-term RAD claims, build a reminder workflow around the six-month mark. Waiting until after the evaluation window closes puts reauthorization — and ongoing reimbursement — at risk.


CMS NIPPV Exclusions and Non-Covered Indications

The CMS NIPPV coverage policy is specific about what doesn't qualify. These exclusions are real denial triggers.

Non-covered conditions include:

#Excluded Procedure
1Patients whose hypercapnia is primarily caused by sleep apnea (not COPD-driven CRF)
2Patients who do not meet the PaCO2 ≥ 52 mmHg threshold by ABG
3RAD with backup rate feature used at settings below the high intensity threshold (IPAP < 15 cm H2O or backup rate < 14 breaths/minute) by the end of the six-month period

The real issue here is the sleep apnea exclusion. Many COPD patients also have obstructive sleep apnea. If sleep apnea is driving the hypercapnia — rather than the COPD — this coverage policy doesn't apply. That distinction has to be documented by the treating clinician. A vague note won't survive a MAC audit.


Coverage Indications at a Glance

Indication Status Relevant Codes Notes
RAD with backup rate feature — high intensity NIV for CRF consequent to COPD (stable or post-hospitalization) Covered Not specified in policy Requires PaCO2 ≥ 52 mmHg, sleep apnea not predominant, plus stability criteria; IPAP ≥ 15 cm H2O and backup rate ≥ 14 bpm required by end of initial 6-month period
RAD without backup rate feature — CRF consequent to COPD, high intensity NIV intolerant or inappropriate Covered Not specified in policy Requires PaCO2 ≥ 52 mmHg, sleep apnea not predominant; documentation of why backup rate is inappropriate required
RAD with or without backup rate — acute on chronic respiratory failure, immediate post-discharge Covered Not specified in policy Patient must have required RAD or ventilator within 24 hrs pre-discharge; clinician must document risk of rapid exacerbation
+ 4 more indications

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

This policy is now in effect (since 2026-03-12). Verify your claims match the updated criteria above.

CMS NIPPV Billing Guidelines and Action Items 2026

The CMS NIPPV billing guidelines under NCD 380 require documentation precision at every stage. Vague clinical notes are the number one cause of preventable claim denial on these cases.

#Action Item
1

Audit all active RAD claims before January 31, 2026. Pull every open DME case involving RADs for COPD-related CRF. Verify that each claim has an ABG documenting PaCO2 ≥ 52 mmHg during awake hours on prescribed FiO2. If that lab result isn't in the file, get it before the effective date.

2

Verify sleep apnea exclusion documentation for every patient. The treating clinician must document that sleep apnea is not the predominant cause of hypercapnia. If the patient also carries a sleep apnea diagnosis, this matters even more. Confirm the physician's note addresses it directly. A diagnosis code alone isn't enough.

3

For RAD with backup rate feature cases, confirm high intensity settings by the six-month mark. At the end of the initial coverage period, the device settings must show IPAP ≥ 15 cm H2O and a backup respiratory rate of at least 14 breaths per minute. Build a workflow to pull device compliance data before the six-month window closes. Contact the prescribing clinician to adjust settings if needed.

+ 4 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Sample Version Diff Line-by-line changes
Previous VersionCurrent Version
Coverage is considered experimental and investigational for all indicationsCoverage is considered medically necessary when specific criteria are met
Prior authorization is not requiredPrior authorization is required for initial treatment
Documentation must include clinical historyDocumentation must include clinical history
+ 1 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

CPT, HCPCS, and ICD-10 Codes for NIPPV Under NCD 380

Covered and Applicable Codes

The policy document for NCD 380 Medicare does not publish specific HCPCS or CPT codes in its current version. This is not unusual for a National Coverage Determination — the code-level mapping typically lives in the associated Local Coverage Determinations (LCDs) and billing articles published by Medicare Administrative Contractors (MACs).

For NIPPV billing, your MAC's LCD is where you'll find the HCPCS codes for RADs (typically in the E-code range for DME) and associated ICD-10-CM diagnosis codes for COPD and CRF. Contact your MAC directly, or check the CMS Coverage Database for the associated LCD linked to NCD 380.

Do not rely on codes from prior versions of this policy or from non-MAC sources without verification. HCPCS codes for RADs have been updated in the past, and billing the wrong code — even for a covered service — triggers a claim denial.


Get the Full Picture

Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.

🔍 Search by any code 🔔 Real-time alerts 📊 Line-by-line diffs ⏰ Deadline tracking
Get Full Access → $99/mo · 14-day money-back guarantee